A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
Government Operations and Politics119-s4066 — A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.. Sponsored by Sen. Hawley, Josh [R-MO]. Introduced 2026-03-11. Senate bill. 119th Congress. Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Sponsor
- Sen. Hawley, Josh [R-MO] (R), MO
- Introduced
- 2026-03-11
- Committees
- Health, Education, Labor, and Pensions Committee
- Latest Action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
No roll-call vote data available for this bill.
Similar Bills
- 119-s68 — Complete COVID Collections Act 52% match
- 118-hr9595 — FIT Procurement Act 52% match 118th Congress
- 118-s4631 — ACCESS Act 50% match 118th Congress
- 118-s1466 — HIKE Act 50% match 118th Congress
- 118-s3392 — AREA Act 49% match 118th Congress
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis